Vitalhub Corp. (TSE:VHI) Receives C$11.60 Average PT from Analysts

Vitalhub Corp. (TSE:VHI) has been given an average recommendation of “Buy” by the five analysts that are covering the company, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy rating. The average 12-month target price among brokerages that have issued a report on the stock in the last year is C$12.08.

Several research analysts have recently weighed in on VHI shares. Canaccord Genuity Group upped their price objective on Vitalhub from C$12.00 to C$12.50 and gave the stock a “buy” rating in a research report on Thursday, January 16th. Scotiabank set a C$14.00 price target on shares of Vitalhub and gave the stock an “outperform” rating in a research note on Thursday, January 30th. TD Securities boosted their price objective on shares of Vitalhub from C$13.00 to C$14.00 and gave the stock a “buy” rating in a research report on Monday. Finally, Raymond James set a C$13.50 target price on shares of Vitalhub and gave the company an “outperform” rating in a research report on Thursday, March 27th.

Vitalhub Trading Down 0.6 %

VHI opened at C$10.01 on Thursday. The stock has a market capitalization of C$541.46 million, a P/E ratio of 162.81, a P/E/G ratio of 1.18 and a beta of 1.26. Vitalhub has a 12 month low of C$5.80 and a 12 month high of C$12.09. The firm’s fifty day simple moving average is C$10.39 and its 200 day simple moving average is C$10.37.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.